Skip to content

Nuvation Bio NUVB Deferred Tax Liabilities - Leasing Arrangements

Deferred Tax Liabilities - Leasing Arrangements at other companies

PepsiCo logo
PepsiCoPEP
$819M+6.1%
MSCI logo
MSCIMSCI
$23.6M-6.5%
Keysight Technologies logo
Keysight TechnologiesKEYS
$52M0.0%
PNC Financial Services logo
PNC Financial ServicesPNC
$798M-13.2%
Bank of America logo
Bank of AmericaBAC
$3.25B+7.4%
State Street logo
State StreetSTT
$240M+21.2%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.25B+150%
Enterprise value$2.18B+154%
P/S15.7×-66.3×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesLeasingArrangements.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's deferred tax liabilities - leasing arrangements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's deferred tax liabilities - leasing arrangements?
Nuvation Bio (NUVB) reported deferred tax liabilities - leasing arrangements of $811K in Q4 2025.
How has Nuvation Bio's deferred tax liabilities - leasing arrangements changed year-over-year?
Nuvation Bio's deferred tax liabilities - leasing arrangements decreased by 4.9% year-over-year, from $853K to $811K.
What is the long-term trend for Nuvation Bio's deferred tax liabilities - leasing arrangements?
Over 4 years (2021 to 2025), Nuvation Bio's deferred tax liabilities - leasing arrangements has grown at a -2.5% compound annual growth rate (CAGR), from $896K to $811K.